Identification of drug interactions by meta-analysis of premarketing trials: The effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate

Jordan L. Holtzman; Charles E. Weeks; Donald C. Kvam; Donald A. Berry; Linda Mottonen; Bruce P. Ekholm; Shaw F. Chang; Gordon J. Conard

doi:10.1038/clpt.1989.99

Identification of drug interactions by meta-analysis of premarketing trials: The effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate

Jordan L. Holtzman, Charles E. Weeks, Donald C. Kvam, Donald A. Berry, Linda Mottonen, Bruce P. Ekholm, Shaw F. Chang, Gordon J. Conard

University of Minnesota Twin Cities

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Original language	English (US)
Pages (from-to)	1-8
Number of pages	8
Journal	Clinical pharmacology and therapeutics
Volume	46
Issue number	1
DOIs	https://doi.org/10.1038/clpt.1989.99
State	Published - Jul 1989

Publisher link

10.1038/clpt.1989.99

Find It

Find It at U of M Libraries

Cite this

Holtzman, J. L., Weeks, C. E., Kvam, D. C., Berry, D. A., Mottonen, L., Ekholm, B. P., Chang, S. F., & Conard, G. J. (1989). Identification of drug interactions by meta-analysis of premarketing trials: The effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate. Clinical pharmacology and therapeutics, 46(1), 1-8. https://doi.org/10.1038/clpt.1989.99

Identification of drug interactions by meta-analysis of premarketing trials: The effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate. / Holtzman, Jordan L.; Weeks, Charles E.; Kvam, Donald C. et al.
In: Clinical pharmacology and therapeutics, Vol. 46, No. 1, 07.1989, p. 1-8.

Research output: Contribution to journal › Article › peer-review

Holtzman, JL, Weeks, CE, Kvam, DC, Berry, DA, Mottonen, L, Ekholm, BP, Chang, SF & Conard, GJ 1989, 'Identification of drug interactions by meta-analysis of premarketing trials: The effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate', Clinical pharmacology and therapeutics, vol. 46, no. 1, pp. 1-8. https://doi.org/10.1038/clpt.1989.99

@article{f04c0107c96445b2ae9b065dc22ecbe7,

title = "Identification of drug interactions by meta-analysis of premarketing trials: The effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate",

author = "Holtzman, {Jordan L.} and Weeks, {Charles E.} and Kvam, {Donald C.} and Berry, {Donald A.} and Linda Mottonen and Ekholm, {Bruce P.} and Chang, {Shaw F.} and Conard, {Gordon J.}",

year = "1989",

month = jul,

doi = "10.1038/clpt.1989.99",

language = "English (US)",

volume = "46",

pages = "1--8",

journal = "Clinical pharmacology and therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Identification of drug interactions by meta-analysis of premarketing trials

T2 - The effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate

AU - Holtzman, Jordan L.

AU - Weeks, Charles E.

AU - Kvam, Donald C.

AU - Berry, Donald A.

AU - Mottonen, Linda

AU - Ekholm, Bruce P.

AU - Chang, Shaw F.

AU - Conard, Gordon J.

PY - 1989/7

Y1 - 1989/7

UR - http://www.scopus.com/inward/record.url?scp=0024373117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024373117&partnerID=8YFLogxK

U2 - 10.1038/clpt.1989.99

DO - 10.1038/clpt.1989.99

M3 - Article

C2 - 2501055

AN - SCOPUS:0024373117

SN - 0009-9236

VL - 46

SP - 1

EP - 8

JO - Clinical pharmacology and therapeutics

JF - Clinical pharmacology and therapeutics

IS - 1

ER -

Identification of drug interactions by meta-analysis of premarketing trials: The effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate

Publisher link

Find It

Other files and links

Cite this